[ad_1]
AstraZeneca will have 200 million doses of its candidate vaccine developed by the University of Oxford by the tip of 2020, with 700 million doses prepared globally by the tip of the primary quarter of 2021, operations govt Pam Cheng stated on Monday.
Cheng advised a briefing that there can be 20 million doses in Britain by the tip of the 12 months, with 70 million doses for the UK by the tip of Q1 2021.
(This story has not been edited by Newslivenation employees and is auto-generated from a syndicated feed.)
PreetiJha